Anebulo Pharmaceuticals, Inc.
ANEB · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $49 | $69 | $59 | $121 |
| - Cash | $12 | $3 | $11 | $15 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $37 | $66 | $48 | $107 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$8 | -$8 | -$12 | -$7 |
| % Margin | – | – | – | – |
| Net Income | -$8 | -$8 | -$12 | -$7 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.25 | -0.32 | -0.47 | -0.29 |
| % Growth | 21.9% | 31.9% | -62.1% | – |
| Operating Cash Flow | -$6 | -$8 | -$10 | -$5 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | -$6 | -$8 | -$10 | -$5 |